June 23, 2026
Written By
Dr. Michael Minh Le
Subscribe to the Premed Catalyst Newsletter
University of Michigan Medical School has a reputation that precedes it, and if you're building your school list, that reputation is probably exactly why you're here. But beyond whether Michigan is a good medical school, you want to know whether it's the right school for your application.
This article breaks down where Michigan Medical School stands in 2026 across U.S. News, global, and research rankings, what's driving those numbers, and how Michigan stacks up against comparable programs. More importantly, it cuts through what the rankings don't tell you, because the gap between a school's prestige and what it actually takes to get in is where most applicants get blindsided.
For that, the Premed Catalyst Application Database gives you access to 8 real AMCAS applications that earned real acceptances to top-ranked schools, including personal statements, Most Meaningful entries, and activity descriptions. See exactly what got people in at schools like Michigan, and use that to build an application that actually competes.
It’s completely free inside our student portal. Create a free account and access your resource here.
Below you'll find Michigan's current position in the U.S. News tier system, how the school was ranked before tiers replaced numbers, where it lands globally on the QS and Times Higher Education rankings, and what its NIH funding rank tells you about the research operation you'd be training inside.
U.S. News replaced its traditional numerical rankings with a four-tier system in 2024. The 2026 edition marks the third iteration of this approach. Schools are grouped into four performance tiers: Tier 1 represents the highest-performing schools at the 85th–99th percentile. Schools that declined to participate or lacked sufficient data are labeled unranked.
In January 2023, Michigan Medicine announced the medical school would no longer participate in U.S. News & World Report rankings, so it’s one of the schools that’s unranked. The move came after several other schools, including Harvard, Duke, Stanford, Cornell, and the University of Chicago, made the same call. Dean Marschall Runge said the school made multiple attempts to push U.S. News toward a methodology overhaul before pulling out entirely.
Before that exit, Michigan was a consistent top-15 program. In the 2022 U.S. News rankings, Michigan was tied for #15 in research and #15 in primary care.
Michigan's global footprint is strong and consistent across both major international ranking bodies.
In the Times Higher Education 2026 World Rankings, the University of Michigan secured the 23rd position among 2,191 global institutions. Among public universities in America, Michigan stands with just three other institutions in the global top 25. UC Berkeley at 9th, UCLA at 18th, and the University of Washington at 25th.
On the QS side, the University of Michigan ranks 45th in the QS World University Rankings 2026, maintaining its position from 2025. Within the subject-specific rankings, QS places Michigan's medicine program at #19 in the world.
This is where Michigan separates itself. Strip away the U.S. News debate entirely and look at NIH funding, the most objective proxy for research volume at an American medical school, and Michigan is a clear top-10 program.
In fiscal year 2025, the University of Michigan received $507,840,724 in NIH funding, ranking 10th among all U.S. medical schools. That's over half a billion dollars in a single year. For context, the medical school's most recent figures show $508M in NIH awards for FFY25, $819M in total sponsored project awards, and $147M in industry-sponsored awards.
The department-level picture is just as strong. Two Michigan departments, Physiology and Urology, rank first in the nation for NIH funding, with four more departments (Biomedical Engineering, Emergency Medicine, Physical Medicine and Rehabilitation, and Surgery) in the top five. Overall, 21 departments rank in the top 15, with 17 in the top 10.
Whether Michigan looks like it’s rising or falling depends on whether you look at the U.S. News historical record, the global rankings, or the NIH data.
Michigan's last years in the U.S. News system showed a program that was stable, not climbing and not falling. In the 2022 rankings, Michigan was tied for #15 in research and #15 in primary care. Those numbers were consistent with where Michigan had sat for years, hovering in the #13–17 band for research across the preceding several cycles.
At the university-wide level, QS has Michigan moving in the wrong direction in raw numbers, from #25 globally in 2023, to #33 in 2024, to #44 in 2025. The 2026 QS ranking lands at #45. That's a real drop in the overall standings over three years. But the subject-specific medicine ranking tells a different story. QS places Michigan's medicine program at #19 in the world.
University of Michigan’s THE ranking has been more stable. Michigan secured the 23rd position in the Times Higher Education 2026 World Rankings, down just one spot from 22nd the prior year. That's essentially flat.
Michigan moved from #13 in NIH funding nationally in federal fiscal year 2022 to #11 in FY2023, with total NIH funding climbing to $482.8 million, an increase of nearly 11% year over year. By fiscal year 2024, that number reached $510 million, putting Michigan at #9 nationally. In fiscal year 2025, Michigan received $507.8 million in NIH funding, ranking #10.
Medical school rankings aren't useless. The metrics behind them capture real things: research output, funding, academic reputation, selectivity. That data is worth knowing. But every ranking system is also built on a specific set of inputs, and what gets left out of the formula is just as important as what gets included.
U.S. News (Research)
Before Michigan exited the system, its research ranking was built on five main factors:
Notably, peer and residency director assessments, which used to account for a large share of the score, were removed starting in the 2024 edition. The current tier system runs entirely on objective metrics.
QS Subject Rankings (Medicine)
QS weights reputation surveys heavily. The medicine subject ranking is built primarily on:
This is why Michigan holds a top-20 medicine position globally even as its overall QS institutional number has drifted. Academic reputation scores in subject-specific rankings are built on years of peer perception. They move slowly and don't react quickly to changes in institutional data.
Times Higher Education
THE's world ranking weighs five broad pillars:
The medicine-specific assessment leans heavily on citation impact and research output, which is where Michigan's half-billion-dollar NIH operation shows up directly.
NIH Funding (Blue Ridge)
This one's simple. It's total federal dollars awarded by the NIH to a medical school and its affiliated hospitals in a given fiscal year. No surveys, no reputation scores, just money awarded for research. That's why it's the most objective signal in this entire article.
Here's what no ranking system captures that actually shapes your training:
The number tells you something. It doesn't tell you everything. And the things it skips are usually the ones that determine what your actual training looks like.
The schools that share Michigan's "unranked" status in 2026 U.S. News are Harvard, Stanford, Johns Hopkins, Columbia, and Penn. This is the most important context you can have when reading Michigan's position. In the final year Michigan participated in U.S. News numerical rankings, it tied for #9 in research, right alongside Duke, and just behind Columbia at #6, Stanford and Yale tied at #7.
When it comes to NIH funding, the cleanest apples-to-apples comparison across unranked and ranked schools alike, Michigan sits at #10 nationally with $507.8 million in FY2025. Johns Hopkins School of Medicine received approximately $571 million in NIH funding in 2024, placing it sixth among medical schools.
That gap is real. Hopkins, Penn, Yale, UCSF, and Washington University in St. Louis all out-fund Michigan on NIH dollars. But Michigan is operating in the same tier, half a billion dollars a year in federal research investment is not a gap you can explain away with prestige alone.
Here's a closer look at how Michigan stacks up against similar programs:
Michigan vs. Northwestern Feinberg
Michigan vs. Northwestern is probably the most direct peer comparison for a premed choosing between two major Midwestern research programs. Feinberg received $435 million in NIH awards in 2024–2025, ranking 16th nationally. Michigan's $507.8 million at #10 puts it roughly $70 million ahead on NIH funding.
Both programs produce graduates who match into competitive specialties, both sit inside major academic medical centers, and both are unranked or inconsistently placed in the current U.S. News tier system. The research operation at Michigan is larger. Feinberg has Chicago and a private school network.
Michigan vs. Pittsburgh
Pitt is another Tier 1 U.S. News research school that's worth a direct look. Pitt received $555.3 million in NIH funding in FY2025, ranking 8th among medical schools, slightly ahead of Michigan's #10 position. On raw NIH dollars, Pitt edges Michigan. Both are public schools. Pitt participates in U.S. News; Michigan doesn't.
If you're weighing these two based on research infrastructure alone, they're close. Pitt has a slight edge in funding volume, Michigan has a stronger global reputation signal from QS and THE.
If you're using it to answer the question "is this a serious program,” then yes, you should care about the ranking.
Michigan's ranking position across NIH funding, global indexes, and its historical U.S. News records all point to the same answer: this is one of the top research medical schools in the country.
If you're using it to decide whether Michigan is the right school for you, then that’s when you stop looking at the rankings.
The ranking can't answer that. It doesn't know what specialty you're going into. It doesn't know whether you want to stay in the Midwest for residency, whether you need in-state tuition to make the debt math work, or whether you're chasing an MD/PhD track that would make Michigan's research infrastructure directly relevant to your training. Those questions are what should actually drive your decision.
So should you care about the ranking? Care enough to understand what the numbers actually say. Don't care so much that you're comparing tier placements between schools that have already cleared every bar that matters. At that level, you're not choosing between good and great. You're choosing between different versions of an incredible opportunity. Make that choice based on fit, not on a formula.
You now know where Michigan stands. You know the NIH numbers, the tier system, what the rankings measure, and what they miss. That's the research side done.
The harder part is building an application that actually gets you in. The best way to close that gap is to read applications that worked.
That's what the Premed Catalyst Application Database gives you. Eight full AMCAS applications that earned real acceptances to top-ranked medical schools, including personal statements, Most Meaningful entries, and activity descriptions. Including my own application to UCLA. It’s completely free inside the Premed Catalyst student portal.
You've done the work to understand where Michigan stands. Now model your app after what it actually takes to get accepted.
Create an account and get your free resource here.
